BBVA Foundation ‘Frontiers of Knowledge’ Award It went to the doctors in the category of biology and biomedicine david baker -from the University of Washington and the Howard Hughes Medical Institute- and Demis Hassabis and John Jumper -from artificial intelligence company DeepMind- is the author of artificial intelligence (ia) that manufacture drugs and that will allow progress in development new treatments.
“He receives the award for his contribution to the use of artificial intelligence to accurately predict the three-dimensional structure of proteins from their primary amino acid sequences,” explains the jury. it is a success “Experienced”.
this novel invention of doctors “This is revolutionizing the understanding of how the amino acid sequences of proteins give rise to uniquely ordered three-dimensional structures. Scientists can now use these new methods to predict protein interactions, design entirely new proteins, and develop novel proteins.” are for finding drug targets.”
development of new treatments
The artificial intelligence developed by Becker, Hassabis and Jumper “will allow us to move very quickly in the development of treatments for many diseases,” they explain. Oscar MarinDirector of the Medical Research Council Center for Neurodevelopmental Disorders at King’s College London (UK) and Jury Secretary.
“Predicting the structure of a protein used to require years of hard work in the laboratory, but thanks to advances made by the three laureates, we now only need a few minutes at the computer to achieve this goal, Marin said.
He explained that the winners have developed a “shortcut” using AI with deep learning methodology. dario alessiDirector and Jury Member of the Protein Phosphorylation and Ubiquitination Unit-MRC at the University of Dundee (United Kingdom).
